Jacob D. Bitran - Publications, H-index & Citations

Jacob D. Bitran

chicago medical school

38H指数

207论文数

4.5K被引数

收录论文 6

发表时间

Advances in Therapy of Adult Patients with Acute Lymphoblastic Leukemia

CELLS

IF5.2

2025-03-01

OAAI

Sucre, Oscar; Pamulapati, Saagar; Muzammil, Zeeshan; Bitran, Jacob

Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer

BRITISH JOURNAL OF CANCER

IF6.8

2012-07-17

OAAI

Nabhan, C.; Villines, D.; Valdez, T. V.; Tolzien, K.; Lestingi, T. M.; Bitran, J. D.; Christner, S. M.; Egorin, M. J.; Beumer, J. H.

Efficacy and Safety of Clofarabine in Relapsed and/or Refractory Non-Hodgkin Lymphoma, Including Rituximab-Refractory Patients 氯法拉滨在复发和/或难治性非霍奇金淋巴瘤 (包括利妥昔单抗难治性患者) 中的疗效和安全性

CANCER

IF5.1

2010-11-08

OAAI

Nabhan, Chadi; Davis, Nancy; Bitran, Jacob D.; Galvez, Angel; Fried, Walter; Tolzien, Kathy; Foss, Susan; Dewey, Wendy M.; Venugopal, Parameswaran

Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: A phase II study with long-term follow-up

CLINICAL COLORECTAL CANCER

IF3.2

2007-03-01

PREAI

Nabhan, Chadi; Ragam, Avanthi; Samuels, Brian; Milton, Daniel T.; Prasad, Leela; Hooberman, Arthur; Hartsell, William.; Anthony, Andi; Weisman, Robert; Bitran, Jacob D.

INVITRO RESISTANCE TO ZIDOVUDINE AND ALPHA-INTERFERON IN HIV-1 ISOLATES FROM PATIENTS - CORRELATIONS WITH TREATMENT DURATION AND RESPONSE 来自患者的HIV-1分离株对齐多夫定和 α-干扰素的体外耐药性-与治疗持续时间和反应的相关性

ANNALS OF INTERNAL MEDICINE

IF15.2

1992-09-15

PREAI

EDLIN, BR; STCLAIR, MH; PITHA, PM; WHALING, SM; KING, DM; BITRAN, JD; WEINSTEIN, RA

GRAFT-VERSUS-HOST DISEASE AND LIVER-TRANSPLANTATION

ANNALS OF INTERNAL MEDICINE

IF15.2

1992-07-15

PREAI

DEPAOLI, AM; BITRAN, J

研究方向